EBR Systems, Inc. announced that a scientific paper describing the use of leadless septal left ventricle (LV) pacing with the WiSE®-CRT system has been published in the leading peer-reviewed journal Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society and the Paediatric & Congenital Electrophysiology Society.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 AUD | -7.02% | +6.00% | +73.77% |
04-26 | Australian Shares Fall on Fading Rate Cut Hopes; BHP Slips 4% on Anglo American Bid Update | MT |
04-26 | EBR Systems on Track to Submit Cardiac Pacing Technology's Final Module to US FDA in Q3 | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+73.77% | 234M | |
+11.18% | 225B | |
+15.22% | 197B | |
+19.19% | 143B | |
+30.89% | 111B | |
+2.62% | 64.72B | |
+18.48% | 54.44B | |
+5.12% | 51.06B | |
+10.53% | 45.03B | |
+5.98% | 37.4B |
- Stock Market
- Equities
- EBR Stock
- News EBR Systems, Inc.
- EBR Systems, Inc. Announces Study of WiSE Published in Heart Rhythm Journal